Choksi Laboratories [CHOKSILA] vs Vimta Labs [VIMTALABS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Choksi Laboratories Ltd. wins in 7 metrics, Vimta Labs Ltd. wins in 12 metrics, with 0 ties. Vimta Labs Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Choksi Laboratories Ltd. | Vimta Labs Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 37.71 | 28.76 | Vimta Labs Ltd. |
| Price-to-Book Ratio | 2.85 | 5.13 | Choksi Laboratories Ltd. |
| Debt-to-Equity Ratio | 120.16 | 1.63 | Vimta Labs Ltd. |
| PEG Ratio | 0.19 | -1.60 | Choksi Laboratories Ltd. |
| EV/EBITDA | 8.86 | 15.59 | Choksi Laboratories Ltd. |
| Profit Margin (TTM) | 4.17% | 18.82% | Vimta Labs Ltd. |
| Operating Margin (TTM) | 7.41% | 23.64% | Vimta Labs Ltd. |
| EBITDA Margin (TTM) | 7.41% | 23.64% | Vimta Labs Ltd. |
| Return on Equity | 6.45% | 17.78% | Vimta Labs Ltd. |
| Return on Assets (TTM) | 2.33% | 14.43% | Vimta Labs Ltd. |
| Free Cash Flow (TTM) | $40.91M | $151.19M | Vimta Labs Ltd. |
| Dividend Yield | N/A | 0.83% | N/A |
| 1-Year Return | 12.14% | -4.01% | Choksi Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 1.58 | 5.44 | Choksi Laboratories Ltd. |
| Enterprise Value | $988.26M | $20.76B | Vimta Labs Ltd. |
| EV/Revenue Ratio | 2.22 | 5.27 | Choksi Laboratories Ltd. |
| Gross Profit Margin (TTM) | 80.48% | 80.37% | Choksi Laboratories Ltd. |
| Revenue per Share (TTM) | $64 | $88 | Vimta Labs Ltd. |
| Earnings per Share (Diluted) | $2.68 | $16.63 | Vimta Labs Ltd. |
| Beta (Stock Volatility) | 0.06 | -0.28 | Vimta Labs Ltd. |
Choksi Laboratories Ltd. vs Vimta Labs Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Choksi Laboratories Ltd. | 2.83% | -7.99% | 21.15% | 31.75% | -6.05% | -3.17% |
| Vimta Labs Ltd. | 0.00% | 12.38% | 7.74% | 19.25% | -16.12% | -14.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Choksi Laboratories Ltd. | 12.14% | 183.17% | 859.21% | 968.12% | 807.14% | 566.67% |
| Vimta Labs Ltd. | -4.01% | 127.88% | 285.95% | 1,215.69% | 2,521.09% | 343.62% |
Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Vimta Labs Ltd.
| Metric | CHOKSILA | VIMTALABS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹703.84M | ₹20.49B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,105 | 185,213 |
| 90 Day Avg. Volume | 4,089 | 174,604 |
| Last Close | ₹125.45 | ₹513.25 |
| 52 Week Range | ₹81.85 - ₹236.70 | ₹376.05 - ₹902.65 |
| % from 52W High | -47.00% | -43.14% |
| All-Time High | ₹236.70 (Aug 20, 2025) | ₹1,178.00 (Feb 10, 2025) |
| % from All-Time High | -47.00% | -56.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.10% |
| Quarterly Earnings Growth | 1.93% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.19% |
| Operating Margin (TTM) | 0.07% | 0.24% |
| Return on Equity (TTM) | 0.06% | 0.18% |
| Debt to Equity (MRQ) | 120.16 | 1.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹35.41 | ₹93.23 |
| Cash per Share (MRQ) | ₹0.45 | ₹12.28 |
| Operating Cash Flow (TTM) | ₹51.38M | ₹812.55M |
| Levered Free Cash Flow (TTM) | ₹15.23M | ₹673.42M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.83% |
| Last 12-Month Dividend | N/A | ₹4.00 |
Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Vimta Labs Ltd.
| Metric | CHOKSILA (Apr 26, 2026) | VIMTALABS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 37.71 | 28.76 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.19 | -1.60 |
| Price to Sales (TTM) | 1.58 | 5.44 |
| Price to Book (MRQ) | 2.85 | 5.13 |
| Market Capitalization | ||
| Market Capitalization | ₹703.84M | ₹20.49B |
| Enterprise Value | ₹988.26M | ₹20.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.22 | 5.27 |
| Enterprise to EBITDA | 8.86 | 15.59 |
| Risk & Other Metrics | ||
| Beta | 0.06 | -0.28 |
| Book Value per Share (MRQ) | ₹35.41 | ₹93.23 |
Financial Statements Comparison: Choksi Laboratories Ltd. vs Vimta Labs Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CHOKSILA (2025) | VIMTALABS (2025) |
|---|---|---|
| Revenue/Sales | 417.82M | 3.44B |
| Cost of Goods Sold | 46.20M | 714.47M |
| COGS % of Revenue | 11.1% | 20.8% |
| Gross Profit | 371.62M | 2.73B |
| Gross Margin | 88.9% | 79.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 50.09M | 906.01M |
| Operating Margin | 12.0% | 26.3% |
| EBITDA | 115.12M | 1.29B |
| EBITDA Margin | 27.6% | 37.6% |
| Pre-Tax Income | 21.53M | 890.00M |
| Pre-Tax Income % of Revenue | 5.2% | 25.9% |
| Income Tax | 6.30M | 222.45M |
| Income Tax % of Revenue | 1.5% | 6.5% |
| Net Income (Profit) | 15.23M | 673.42M |
| Profit Margin | 3.6% | 19.6% |
Balance Sheet & Liquidity Metrics
| Metric | CHOKSILA (2025) | VIMTALABS (2025) |
|---|---|---|
| Cash & Equivalents | 6.12M | 158.36M |
| Total Current Assets | 163.21M | 1.88B |
| Total Current Assets % of Revenue | 39.1% | 54.6% |
| Total Current Liabilities | 238.75M | 643.67M |
| Total Current Liabilities % of Revenue | 57.1% | 18.7% |
| Long-Term Debt | 159.63M | 32.24M |
| Long-Term Debt % of Revenue | 38.2% | 0.9% |
| Total Shareholders Equity | 236.05M | 3.79B |
| Retained Earnings | 150.56M | 2.80B |
| Retained Earnings % of Revenue | 36.0% | 81.4% |
| Property, Plant & Equipment | 471.35M | 89.36M |
Cash Flow Statement Comparison
| Metric | CHOKSILA (2025) | VIMTALABS (2025) |
|---|---|---|
| Operating Cash Flow | 51.38M | 812.55M |
| Operating Cash Flow % of Revenue | 12.3% | 23.6% |
| Capital Expenditures | -74.37M | -761.90M |
| Free Cash Flow | 40.91M | 151.19M |
| FCF Margin | 9.8% | 4.4% |
| Debt Repayment | -58.75M | -116.50M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CHOKSILA | VIMTALABS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 6.97M | 44.67M |
| Float Shares | 3.14M | 15.14M |
| % Held by Insiders | 60.49% | 65.84% |
| % Held by Institutions | 0.00% | 4.16% |
| % Held by Public | 39.51% | 30.00% |
Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Vimta Labs Ltd.
| Metric | CHOKSILA | VIMTALABS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.00 |
| Last 12-Month Dividend Yield | N/A | 0.83% |
| 3-Year Avg Annual Dividend | N/A | ₹2.00 |
| 3-Year Avg Dividend Yield | N/A | 0.44% |
| 3-Year Total Dividends | N/A | ₹6.00 |
| Ex-Dividend Date | N/A | May 30, 2025 |